Polaroid Therapeutics

Service
Thought Leadership
Industry
Healthcare
Background Image
(Overview)

Polaroid Therapeutics (PTx) is a Swiss-based biotech company working to address Antimicrobial Resistance (AMR) with cutting edge wound care technology, set to launch commercially in 2025. With AMR directly responsible for 1.27 million deaths globally each year, the company stands to make real societal impact. But, as a relatively new organisation, PTx needed to rapidly increase its brand authority in order to forge critical industry partnerships. R. Agency developed and implemented an earned media strategy including product and business storytelling, thought leadership and profiling in prominent health and biotech media outlets. The resulting coverage successfully positions PTx as a thought leader in the space.

(Project Details)

Polaroid Therapeutics, a biotech start-up, is focused on combating antimicrobial resistance (AMR) with its groundbreaking wound care technology. The advanced wound dressings will be launched commercially in 2025. But awareness of the company was relatively low within the target industry of wound management. To address this, PTx tasked R. Agency with increasing widespread awareness of PTx as an innovative leader in biotech, showcasing the company’s expertise by highlighting major milestones and attracting industry support and building momentum for change.

Polaroid Therapeutics is set to change the world of antimicrobial resistance (AMR) with its groundbreaking wound care technology, presented as wound dressings to be launched commercially in 2025. Ahead of this launch PTx tasked R. Agency with increasing widespread awareness of Polaroid Therapeutics as an innovative leader in biotech, showcasing the company’s expertise by highlighting major milestones, attracting industry support and building momentum for change.

Results

In 2024, PTx received 346 pieces of media coverage, with a combined reach of 298 million. This includes coverage in standout titles such as Medical Device Network, Fierce Biotech and Pharmaceutical Technology. The coverage has also led to several inquiries from major industry players as a result of increased curiosity and discussions around the brand.